Zobrazeno 1 - 10 of 24 091 pro vyhledávání: '"NEBIVOLOL"'
1
Akademický článek
Nebivolol, an FDA-Approved Drug, Has General Antibacterial and Antibiofilm Effects and Increases Pseudomonas aeruginosa Tolerance to Ciprofloxacin.
Autor: Schlichter Kadosh, Yael1 (AUTHOR) shlicter@post.bgu.ac.il, Goorevitch, Noa1 (AUTHOR), Teralı, Kerem2 (AUTHOR), Gopas, Jacob3 (AUTHOR), Kushmaro, Ariel1,4,5 (AUTHOR) arielkus@bgu.ac.il
Publikováno v: Pharmaceuticals (14248247). Nov2024, Vol. 17 Issue 11, p1472. 8p.
Zobrazit plný text záznamu
2
Akademický článek
Design of new boron-doped carbon dots for nano-level assay of nebivolol in human plasma and commercial products; Application to greenness assessments.
Autor: AlSalem HS; Department of Chemistry, College of Science, Princess Nourah bint Abdulrahman University, P.O. Box 84428, Riyadh 11671, Saudi Arabia., Alharbi SN; Department of Chemistry, College of Science, Princess Nourah bint Abdulrahman University, P.O. Box 84428, Riyadh 11671, Saudi Arabia., Al-Goul ST; Department of Chemistry, College of Sciences & Arts, King Abdulaziz University, Rabigh, Saudi Arabia., Salman BI; Department of Pharmaceutical Analytical Chemistry, Faculty of Pharmacy, Al-Azhar University, Assiut Branch, Assiut 71524, Egypt., Hassan YF; Department of Pharmaceutical Analytical Chemistry, Faculty of Pharmacy, Al-Azhar University, Assiut Branch, Assiut 71524, Egypt., Abdel-Lateef MA; Department of Pharmaceutical Analytical Chemistry, Faculty of Pharmacy, Al-Azhar University, Assiut Branch, Assiut 71524, Egypt. Electronic address: mohamed_abdellateef@azhar.edu.eg.
Publikováno v: Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy [Spectrochim Acta A Mol Biomol Spectrosc] 2024 Oct 05; Vol. 318, pp. 124470. Date of Electronic Publication: 2024 May 14.
Zobrazit plný text záznamu
3
Akademický článek
Nebivolol prevents redox imbalance and attenuates bladder dysfunction induced by cyclophosphamide in mice.
Autor: Jesus CPS; Laboratório de Farmacologia, Escola de Enfermagem de Ribeirão Preto, Universidade de São Paulo (USP), Ribeirão Preto, São Paulo, Brazil.; Programa de Pós-graduação em Farmacologia, Faculdade de Medicina de Ribeirão Preto, USP, Ribeirão Preto, São Paulo, Brazil., Pimenta GF; Laboratório de Farmacologia, Escola de Enfermagem de Ribeirão Preto, Universidade de São Paulo (USP), Ribeirão Preto, São Paulo, Brazil.; Programa de Pós-graduação em Farmacologia, Faculdade de Medicina de Ribeirão Preto, USP, Ribeirão Preto, São Paulo, Brazil., de Oliveira MG; Departamento de Farmacologia, Faculdade de Ciências Médicas, Universidade Estadual de Campinas (UNICAMP), Campinas, São Paulo, Brazil., Dourado TMH; Laboratório de Farmacologia, Escola de Enfermagem de Ribeirão Preto, Universidade de São Paulo (USP), Ribeirão Preto, São Paulo, Brazil.; Programa de Pós-graduação em Farmacologia, Faculdade de Medicina de Ribeirão Preto, USP, Ribeirão Preto, São Paulo, Brazil., Antunes E; Departamento de Farmacologia, Faculdade de Ciências Médicas, Universidade Estadual de Campinas (UNICAMP), Campinas, São Paulo, Brazil., Tirapelli CR; Laboratório de Farmacologia, Escola de Enfermagem de Ribeirão Preto, Universidade de São Paulo (USP), Ribeirão Preto, São Paulo, Brazil.; Departamento de Ciências BioMoleculares, Faculdade de Ciências Farmacêuticas de Ribeirão Preto, USP, Ribeirão Preto, São Paulo, Brazil.
Publikováno v: Canadian journal of physiology and pharmacology [Can J Physiol Pharmacol] 2024 Dec 01; Vol. 102 (12), pp. 729-740. Date of Electronic Publication: 2024 Sep 13.
Zobrazit plný text záznamu
4
Akademický článek
The Effects of Nebivolol-Gefitinib-Loratadine Against Lung Cancer Cell Lines.
Autor: Martínez-Lira JL; Departamento de Farmacología, Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional (Cinvestav-IPN), Ciudad de México, México.; UMAE, Hospital de Especialidades Nο. 25, Instituto Mexicano del Seguro Social, Monterrey Nuevo León, México., Hernández-Gallegos E; Departamento de Farmacología, Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional (Cinvestav-IPN), Ciudad de México, México., DE Guadalupe Chávez-López M; Departamento de Farmacología, Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional (Cinvestav-IPN), Ciudad de México, México., Villalobos-Valencia R; Departamento de Oncología Médica, Hospital de Oncología, Centro Médico Nacional Siglo XXI, Instituto Mexicano del Seguro Social, Ciudad de México, México., Camacho J; Departamento de Farmacología, Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional (Cinvestav-IPN), Ciudad de México, México; fcamacho@cinvestav.mx.
Publikováno v: In vivo (Athens, Greece) [In Vivo] 2024 Nov-Dec; Vol. 38 (6), pp. 2688-2695.
Zobrazit plný text záznamu
5
Akademický článek
Enhanced eNOS/nitric oxide production by nebivolol interferes with TGF-β1/Smad3 signaling and collagen I deposition in the kidney after prolonged tacrolimus administration.
Autor: Azouz AA; Department of Pharmacology & Toxicology, Faculty of Pharmacy, Beni-Suef University, Beni-Suef 62514, Egypt. Electronic address: amany.azoz@pharm.bsu.edu.eg., Tohamy MA; Department of Biochemistry, Faculty of Pharmacy, Beni-Suef University, Beni-Suef 62514, Egypt., Ali FEM; Department of Pharmacology & Toxicology, Faculty of Pharmacy, Al-Azhar University, Assiut Branch, Assiut 71524, Egypt; Michael Sayegh, Faculty of Pharmacy, Aqaba University of Technology, Aqaba 77110, Jordan., Mahmoud HM; Department of Pharmacology & Toxicology, Faculty of Pharmacy, Beni-Suef University, Beni-Suef 62514, Egypt.
Publikováno v: Life sciences [Life Sci] 2024 Oct 15; Vol. 355, pp. 122995. Date of Electronic Publication: 2024 Aug 17.
Zobrazit plný text záznamu
6
Akademický článek
The β 2 -adrenergic biased agonist nebivolol inhibits the development of Th17 and the response of memory Th17 cells in an NF-κB-dependent manner.
Autor: Hajiaghayi M; Department of Biology, Concordia University, Montréal, QC, Canada., Gholizadeh F; Department of Biology, Concordia University, Montréal, QC, Canada., Han E; Department of Health, Kinesiology and Applied Physiology, Concordia University, Montréal QC, Canada., Little SR; Department of Electrical and Computer Engineering, Concordia University, Center of Applied Synthetic Biology, Montréal, QC, Canada., Rahbari N; Department of Electrical and Computer Engineering, Concordia University, Center of Applied Synthetic Biology, Montréal, QC, Canada., Ardila I; Department of Biology, Concordia University, Montréal, QC, Canada., Lopez Naranjo C; Department of Biology, Concordia University, Montréal, QC, Canada., Tehranimeh K; Department of Health, Kinesiology and Applied Physiology, Concordia University, Montréal QC, Canada., Shih SCC; Department of Electrical and Computer Engineering, Concordia University, Center of Applied Synthetic Biology, Montréal, QC, Canada., Darlington PJ; Department of Biology, Concordia University, Montréal, QC, Canada.; Department of Health, Kinesiology and Applied Physiology, Concordia University, Montréal QC, Canada.
Publikováno v: Frontiers in immunology [Front Immunol] 2024 Oct 09; Vol. 15, pp. 1446424. Date of Electronic Publication: 2024 Oct 09 (Print Publication: 2024).
Zobrazit plný text záznamu
7
Akademický článek
Assessment of nebivolol efficacy in experimental models of toxoplasmosis: insights into parasite burden reduction and neuronal protection.
Autor: da Silva Bellini Ramos AB; Departamento de Análises Clínicas e Toxicológicas, Faculdade de Ciências Farmacêuticas, Universidade Federal de Alfenas, Alfenas, Brazil., Torres T; Laboratory of Preclinical Assays and Research of Alternative Sources of Innovative Therapy for Toxoplasmosis and Other Sicknesses (PARASITTOS), Faculdade de Medicina de Jundiaí, Jundiaí, Brazil., Dos Reis LFC; Departamento de Biologia Estrutural, Instituto de Ciências Biomédicas, Universidade Federal de Alfenas, Alfenas, Brazil., Lambert GC; Departamento de Análises Clínicas e Toxicológicas, Faculdade de Ciências Farmacêuticas, Universidade Federal de Alfenas, Alfenas, Brazil., Colombo FA; Departamento de Análises Clínicas e Toxicológicas, Faculdade de Ciências Farmacêuticas, Universidade Federal de Alfenas, Alfenas, Brazil., Marques MJ; Departamento de Análises Clínicas e Toxicológicas, Faculdade de Ciências Farmacêuticas, Universidade Federal de Alfenas, Alfenas, Brazil., Reimão JQ; Laboratory of Preclinical Assays and Research of Alternative Sources of Innovative Therapy for Toxoplasmosis and Other Sicknesses (PARASITTOS), Faculdade de Medicina de Jundiaí, Jundiaí, Brazil. julianareimao@g.fmj.br.
Publikováno v: Parasitology research [Parasitol Res] 2024 Aug 20; Vol. 123 (8), pp. 303. Date of Electronic Publication: 2024 Aug 20.
Zobrazit plný text záznamu
8
Akademický článek
Cyclodextrin complexation as a fruitful strategy for improving the performance of nebivolol delivery from solid lipid nanoparticles.
Autor: Mura P; Department of Chemistry, School of Sciences of Human Health, University of Florence, via Schiff 6, Sesto Fiorentino, 50019 Florence, Italy., Maestrelli F; Department of Chemistry, School of Sciences of Human Health, University of Florence, via Schiff 6, Sesto Fiorentino, 50019 Florence, Italy. Electronic address: francesca.maestrelli@unifi.it., Gonçalves LMD; Research Institute for Medicines and Pharmaceutical Sciences (iMed.UL), Faculty of Pharmacy, University of Lisbon, Av. Prof. Gama Pinto, 1649-003 Lisboa, Portugal., Cirri M; Department of Chemistry, School of Sciences of Human Health, University of Florence, via Schiff 6, Sesto Fiorentino, 50019 Florence, Italy., Mennini N; Department of Chemistry, School of Sciences of Human Health, University of Florence, via Schiff 6, Sesto Fiorentino, 50019 Florence, Italy., Almeida AJ; Research Institute for Medicines and Pharmaceutical Sciences (iMed.UL), Faculty of Pharmacy, University of Lisbon, Av. Prof. Gama Pinto, 1649-003 Lisboa, Portugal.
Publikováno v: International journal of pharmaceutics [Int J Pharm] 2025 Jan 05; Vol. 668, pp. 124972. Date of Electronic Publication: 2024 Nov 19.
Zobrazit plný text záznamu
9
Akademický článek
Nebivolol protects the liver against lipopolysaccharide-induced oxidative stress, inflammation, and endoplasmic reticulum-related apoptosis through Chop and Bip/GRP78 signaling.
Autor: Unal O; Department of Infectious Diseases and Clinical Microbiology, Faculty of Medicine, Suleyman Demirel University, Isparta, Turkey. onurunal@sdu.edu.tr., Erzurumlu Y; Department of Biochemistry, Faculty of Pharmacy, Suleyman Demirel University, Isparta, Turkey., Asci H; Department of Pharmacology, Faculty of Medicine, Suleyman Demirel University, Isparta, Turkey., Gunduru Acar B; Department of Pharmacology, Faculty of Medicine, Suleyman Demirel University, Isparta, Turkey., Bedir M; Department of Biochemistry, Faculty of Medicine, Suleyman Demirel University, Isparta, Turkey., Ozmen O; Department of Pathology, Faculty of Veterinary Medicine, Burdur Mehmet Akif Ersoy University, Burdur, Turkey.
Publikováno v: Naunyn-Schmiedeberg's archives of pharmacology [Naunyn Schmiedebergs Arch Pharmacol] 2024 Aug; Vol. 397 (8), pp. 5899-5907. Date of Electronic Publication: 2024 Feb 14.
Zobrazit plný text záznamu
10
Akademický článek
Extemporaneous combination therapy with nebivolol/ramipril for the treatment of hypertension: a real-world evidence study in Europe.
Autor: Desideri G; Department of Clinical, Internal, Anesthesiologic and Cardiovascular Sciences, Sapienza University of Rome, Rome, Italy., Pegoraro V; IQVIA Solutions Italy S.r.l., Milan, Italy., Cipelli R; IQVIA Solutions Italy S.r.l., Milan, Italy., Ripellino C; IQVIA Solutions Italy S.r.l., Milan, Italy., Miroddi M; A. Menarini Farmaceutica Internazionale S.r.l., Florence, Italy., Meto S; A. Menarini Industrie Farmaceutiche Riunite S.r.l., Florence, Italy., Gori M; Menarini Ricerche SpA, Pomezia, Italy., Fabrizzi P; A. Menarini Industrie Farmaceutiche Riunite S.r.l., Florence, Italy.
Publikováno v: Current medical research and opinion [Curr Med Res Opin] 2024 Jul; Vol. 40 (7), pp. 1093-1102. Date of Electronic Publication: 2024 Jun 13.
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje